Fortrea Clinical Research Unit
Fortrea Clinical Research Unit
Dallas, Texas, United States11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Single and Multiple Doses of LY5625573 in Healthy Participants, Including Japanese and Chinese Populations, and Participants With Inflammation (High C-Reactive Protein) | C-Reactive Protein | Not yet recruiting | Phase 1 | 2026-10-09 | NCT07867340 | |
| A Study of LY5625575 in Healthy Participants and in Participants With Inflammation (Elevated C-Reactive Protein) | C-Reactive Protein; Healthy Volunteers | Recruiting | Phase 1 | 2026-10-09 | NCT07801300 | |
| A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-10-08 | NCT07808073 | |
| A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-10-08 | NCT07808060 | |
| A Study of LY4355756 in Healthy Participants | Healthy | Recruiting | Phase 1 | 2026-10-08 | NCT07765498 | |
| A Study of LY3867070 in Healthy Participants | Healthy | Active, not recruiting | Phase 1 | 2026-10-06 | NCT07021547 | |
| A Study of LY3537031 in Overweight, Obese, and Healthy Participants | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 | 2026-09-30 | NCT06606106 | |
| A Study of Eloralintide (LY3841136) in Healthy Participants | Healthy Volunteers | Active, not recruiting | Phase 1 | 2026-09-29 | NCT07701083 | |
| A Study of LY4515100 in Healthy Participants | Healthy | Recruiting | Phase 1 | 2026-07-29 | NCT07339722 | |
| A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 | 2026-07-16 | NCT07476118 | |
| A Study of Mirikizumab Solution (LY3074828) in Healthy Participants | Healthy | Recruiting | Phase 1 | 2026-05-14 | NCT07446101 |